Journal
VIRUS RESEARCH
Volume 339, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.virusres.2023.199258
Keywords
African swine fever virus; Tetrandrine; Macropinocytosis; PI3K/Akt; Broad-spectrum antiviral drug
Categories
Ask authors/readers for more resources
African Swine Fever Virus (ASFV) causes a severe disease in pigs with no effective treatment available. This study found that Tetrandrine (TET) inhibits ASFV by blocking macropinocytosis through the PI3K/Akt pathway. TET also shows inhibitory effects against other viruses like Lumpy Skin Disease Virus and Porcine Epidemic Diarrhea Virus.
African Swine Fever Virus (ASFV) infection causes an acute and highly contagious disease in swine, resulting in significant economic losses and societal harm worldwide. Currently, there are no effective vaccines or antiviral drugs available for ASFV. Tetrandrine (TET) is extracted from the traditional Chinese herb Stephania tetrandrae, possesses diverse biological functions such as anti-inflammatory, anti-tumor, and antiviral activities. The study comprehensively evaluated the anti-ASFV effect of TET and validated it through biological assays. The dose-dependent inhibition of TET against ASFV was confirmed and a novel mechanism of TET's anti-ASFV activity was elucidated. TET effectively inhibits ASFV during internalization by blocking macropinocytosis through the inhibition of the PI3K/Akt pathway. The specific inhibitor LY294002, targeting the PI3K/Akt pathway, exhibits similar antiviral activity against ASFV as TET. Furthermore, the inhibitory effect of TET against other viruses such as Lumpy Skin Disease Virus (LSDV) and Porcine Epidemic Diarrhea Virus (PEDV) was also identified. Our findings suggest that TET effectively inhibits ASFV and reveal the potential for broad-spectrum antiviral drugs targeting the PI3K/Akt pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available